ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 92 filers reported holding ASCENDIS PHARMA A/S in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,292,512 | +12.4% | 13,803 | +7.1% | 0.00% | +50.0% |
| Q2 2023 | $1,149,719 | -36.5% | 12,882 | -23.7% | 0.00% | -50.0% |
| Q1 2023 | $1,810,624 | -24.9% | 16,887 | -14.4% | 0.00% | -33.3% |
| Q4 2022 | $2,410,113 | -0.6% | 19,734 | -16.0% | 0.01% | -14.3% |
| Q3 2022 | $2,425,000 | -11.5% | 23,489 | -20.3% | 0.01% | 0.0% |
| Q2 2022 | $2,740,000 | -58.7% | 29,484 | -47.8% | 0.01% | 0.0% |
| Q1 2022 | $6,630,000 | +68.2% | 56,494 | +92.9% | 0.01% | -12.5% |
| Q4 2021 | $3,941,000 | -16.6% | 29,288 | -1.2% | 0.01% | -33.3% |
| Q3 2021 | $4,727,000 | +22.9% | 29,656 | +1.4% | 0.01% | +9.1% |
| Q2 2021 | $3,847,000 | -6.1% | 29,238 | -8.0% | 0.01% | -21.4% |
| Q1 2021 | $4,096,000 | -3.0% | 31,786 | +25.5% | 0.01% | -12.5% |
| Q4 2020 | $4,223,000 | +8.9% | 25,318 | +0.7% | 0.02% | -15.8% |
| Q3 2020 | $3,879,000 | +30.1% | 25,135 | +24.7% | 0.02% | +5.6% |
| Q2 2020 | $2,982,000 | +23.7% | 20,162 | -5.8% | 0.02% | -5.3% |
| Q1 2020 | $2,410,000 | -1.5% | 21,398 | +21.7% | 0.02% | +26.7% |
| Q4 2019 | $2,446,000 | +120.6% | 17,585 | +52.7% | 0.02% | +87.5% |
| Q3 2019 | $1,109,000 | -17.1% | 11,513 | -0.9% | 0.01% | -11.1% |
| Q2 2019 | $1,338,000 | -16.1% | 11,616 | -14.3% | 0.01% | -25.0% |
| Q1 2019 | $1,595,000 | +125.3% | 13,551 | +20.0% | 0.01% | +100.0% |
| Q4 2018 | $708,000 | +18.4% | 11,294 | +33.8% | 0.01% | +50.0% |
| Q3 2018 | $598,000 | +169.4% | 8,444 | +153.0% | 0.00% | +33.3% |
| Q2 2018 | $222,000 | +2.8% | 3,337 | +0.9% | 0.00% | 0.0% |
| Q1 2018 | $216,000 | – | 3,306 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |